Targeting the sinusoidal-to-capillarized transition to normalize vessels in breast cancer liver metastasis
- 1Sun Yat-sen University Cancer Center
Abstract
Liver metastases exhibit marked resistance to anti-VEGF anti-angiogenic therapies, yet the underlying mechanisms remain poorly understood. By combining single-cell RNA sequencing of human breast cancer liver metastases with a liver sinusoidal endothelial cell (LSEC) lineage-tracing mouse model, we show that liver metastasis-associated vessels originate from Lyve1+ sinusoidal endothelial cells but undergo a sinusoidal-to-capillarized transition as they grow into the metastatic nodule, characterized by enhanced inflammatory signaling, loss of sinusoidal markers, and acquisition of capillarized markers. We functionally perturbed each of these abnormalities individually. Unexpectedly, ectopic Lyve1 overexpression paradoxically enhanced hyaluronan and other extracellular matrix deposition in the tumor microenvironment, suggesting a compensatory mechanism. Similarly, targeting TNF signaling, a hallmark inflammatory pathway in liver metastasis, dampened the inflammatory state of metastasis-associated vessels but promoted metastatic outgrowth, indicating that TNF blockade is not a viable strategy for metastasis treatment. Strikingly, inhibition of the capillary tip cell marker Esm1 improved vessel perfusion and enhanced chemotherapeutic drug delivery, two defining features of vascular normalization. Pan-cancer analysis further revealed that Esm1 expression is restricted to tip cells and correlates with poor patient prognosis, positioning Esm1 as a candidate target for promoting vascular normalization. Collectively, our findings reveal the vascular plasticity of liver metastasis and, although not all abnormal features are actionable, we propose targeting Esm1 to inhibit sprouting angiogenesis and to normalize dysfunctional liver metastasis vessels, offering a promising therapeutic avenue for liver malignancies.
Related
- Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patients, volume II
- Targeting MicroRNAs in the perioperative window to prevent surgery-induced metastasis and postoperative cancer recurrence
- Targeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy
- Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction
- LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion.
BibTeX
@misc{huang2026targeting,
title = {{Targeting the sinusoidal-to-capillarized transition to normalize vessels in breast cancer liver metastasis}},
author = {H.-Y. Huang and C. Zhao and X.-N. Zheng and Y.-X. Shi and L. Tian},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.28.762442},
url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762442v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Targeting the sinusoidal-to-capillarized transition to normalize vessels in breast cancer liver metastasis
AU - H.-Y. Huang
AU - C. Zhao
AU - X.-N. Zheng
AU - Y.-X. Shi
AU - L. Tian
PY - 2026
DA - 2026/10/28
PB - bioRxiv
DO - 10.64898/2026.10.28.762442
UR - https://www.biorxiv.org/content/10.64898/2026.10.28.762442v1
AB - Liver metastases exhibit marked resistance to anti-VEGF anti-angiogenic therapies, yet the underlying mechanisms remain poorly understood. By combining single-cell RNA sequencing of human breast cancer liver metastases with a liver sinusoidal endothelial cell (LSEC) lineage-tracing mouse model, we show that liver metastasis-associated vessels originate from Lyve1+ sinusoidal endothelial cells but undergo a sinusoidal-to-capillarized transition as they grow into the metastatic nodule, characterized by enhanced inflammatory signaling, loss of sinusoidal markers, and acquisition of capillarized markers. We functionally perturbed each of these abnormalities individually. Unexpectedly, ectopic Lyve1 overexpression paradoxically enhanced hyaluronan and other extracellular matrix deposition in the tumor microenvironment, suggesting a compensatory mechanism. Similarly, targeting TNF signaling, a hallmark inflammatory pathway in liver metastasis, dampened the inflammatory state of metastasis-associated vessels but promoted metastatic outgrowth, indicating that TNF blockade is not a viable strategy for metastasis treatment. Strikingly, inhibition of the capillary tip cell marker Esm1 improved vessel perfusion and enhanced chemotherapeutic drug delivery, two defining features of vascular normalization. Pan-cancer analysis further revealed that Esm1 expression is restricted to tip cells and correlates with poor patient prognosis, positioning Esm1 as a candidate target for promoting vascular normalization. Collectively, our findings reveal the vascular plasticity of liver metastasis and, although not all abnormal features are actionable, we propose targeting Esm1 to inhibit sprouting angiogenesis and to normalize dysfunctional liver metastasis vessels, offering a promising therapeutic avenue for liver malignancies.
ER -